摘要
脓毒症是全身炎症反应的临床表现,炎性细胞因子在炎症的反应过程中具有广泛的生理功能,是引起重症感染,感染性休克,多器官功能衰竭以至死亡的主要因素,维持机体应急状态下的自身稳定是治疗脓毒症的努力目标。针对革兰阴性菌感染所引起的脓毒症,寻找防止细菌的侵袭,提高机体免疫力的有效处理手段,我们首先制备并获得了M2B这株单克隆抗体,采用脓毒症大鼠预先给以M2B的方法,观察了M2B在脓毒症16h动物存活率和细胞因子的变化。本文结果表明预先给以M2B处理,动物在盲肠结扎穿孔16h存活率为90%,而未预处理者存活率为33%。手术前4h,2h动物分别接受从腹腔给预M2B1mg/kg预治疗,测定大鼠血中的3种细胞因子:肿瘤坏死因子(TNF),白细胞介素1(IL-1),白细胞介素6(IL-6)。正常组,脓毒症组,治疗组分别为:(1)TNF:(19.18±4.33)细胞毒性%、(39.93±3.84)和(27.92±6.89)细胞毒性%。(2)IL-1:(29.80±3.20)kU/L、(142.25±27.46)和(67.33±27.35)kU/L。(3)IL-6:(8.33±4.08)kU/L、(25.27±6.40)和(8.7?
The clinical manifestations of sepsis are the expressions of systemic inflammatory response mediated by endogenous mediators and cytokines secreated by the infected individual himself. Based on this understanding, various new approaches of anti inflammatory therapies for interrupting the inflammatory cascade have been investgigated. This study was designed to evaluate the effects of monoclonal antibody against endotoxin M2B on TNF, IL 1, and IL 6 in the septic rats. Sepsis were produced in rats by method of cecal ligation and perforation (CLP). Treatment animnals received M2B 2mg/kg prior to CLP. Results showed that serum TNF levels reduced from the sepsis group of 39.93±3.84 to 27.94±6.89%, (lysis P <0.01) in the treatment group, IL 1 from 142.25±27.46 to 67.33±27.35 kU/L( P <0.01); and IL 6 from 25.27±6.40 to 8.77±2.97 kU/L ( P <0.05). It is thus concluded that monclonal antibody M2B may be a useful agent in fighting sepsis if properly used in selected patients.
出处
《军医进修学院学报》
CAS
1997年第3期202-204,共3页
Academic Journal of Pla Postgraduate Medical School
基金
国家自然科学基金
关键词
脓毒症
内毒素
肿瘤坏死因子
单克隆抗体
IL
sepsis
monoclonal antibody against endotoxin
endotoxins, TNF
interleukins
rats